wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33785935-6399CF20-54DE-4F5F-82B6-DB9F5EBFA6CA
Q33785935-6399CF20-54DE-4F5F-82B6-DB9F5EBFA6CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785935-6399CF20-54DE-4F5F-82B6-DB9F5EBFA6CA
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.
P2860
Q33785935-6399CF20-54DE-4F5F-82B6-DB9F5EBFA6CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785935-6399CF20-54DE-4F5F-82B6-DB9F5EBFA6CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5008feb18265fed6e79f02dafab505d6cd3c067c
P2860
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone.